_version_ 1783624893703651328
author Muntañola, Ana
Villacampa, Guillermo
Hernández-Rivas, José Ángel
Alonso, Rosalía
Mirás, Fátima
Osorio, Santiago
Baile, Mónica
Baltasar, Patricia
López Jiménez, Javier
Hernandez-Rodriguez, Ines
Valenciano, Susana
Alfayate, Ana
Gimeno, Eva
Bárez, Abelardo
Oliveira, Ana C.
Riaza, Rosalía
Romero, Pilar
Delgado, Julio
Yáñez, Lucrecia
Zabalza, Amaya
Torres, Ana
Gómez-Roncero, Mª Isabel
Crespo, Marta
Córdoba, Raúl
Mateos-Mazón, Juan José
Pérez, Sonia
Andreu, Rafael
Labrador, Jorge
Ruiz, Mª Elena
Velasquez, César Andrés
Terol, Mª José
Santiago, Raquel
Vidal, Mª Jesús
Campoy García, Fiz
Villalón, Lucía
Muiña, Begoña S.
Soler, Joan Alfons
Seri, Cristina
Sánchez, Mª José
Cuesta, Amalia
Ramos, Rafael
Sánchez-Montalvá, Adrián
Ruiz-Camps, Isabel
González, Marcos
Abrisqueta, Pau
Bosch, Francesc
author_facet Muntañola, Ana
Villacampa, Guillermo
Hernández-Rivas, José Ángel
Alonso, Rosalía
Mirás, Fátima
Osorio, Santiago
Baile, Mónica
Baltasar, Patricia
López Jiménez, Javier
Hernandez-Rodriguez, Ines
Valenciano, Susana
Alfayate, Ana
Gimeno, Eva
Bárez, Abelardo
Oliveira, Ana C.
Riaza, Rosalía
Romero, Pilar
Delgado, Julio
Yáñez, Lucrecia
Zabalza, Amaya
Torres, Ana
Gómez-Roncero, Mª Isabel
Crespo, Marta
Córdoba, Raúl
Mateos-Mazón, Juan José
Pérez, Sonia
Andreu, Rafael
Labrador, Jorge
Ruiz, Mª Elena
Velasquez, César Andrés
Terol, Mª José
Santiago, Raquel
Vidal, Mª Jesús
Campoy García, Fiz
Villalón, Lucía
Muiña, Begoña S.
Soler, Joan Alfons
Seri, Cristina
Sánchez, Mª José
Cuesta, Amalia
Ramos, Rafael
Sánchez-Montalvá, Adrián
Ruiz-Camps, Isabel
González, Marcos
Abrisqueta, Pau
Bosch, Francesc
author_sort Muntañola, Ana
collection PubMed
description
format Online
Article
Text
id pubmed-7746919
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77469192020-12-18 Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country Muntañola, Ana Villacampa, Guillermo Hernández-Rivas, José Ángel Alonso, Rosalía Mirás, Fátima Osorio, Santiago Baile, Mónica Baltasar, Patricia López Jiménez, Javier Hernandez-Rodriguez, Ines Valenciano, Susana Alfayate, Ana Gimeno, Eva Bárez, Abelardo Oliveira, Ana C. Riaza, Rosalía Romero, Pilar Delgado, Julio Yáñez, Lucrecia Zabalza, Amaya Torres, Ana Gómez-Roncero, Mª Isabel Crespo, Marta Córdoba, Raúl Mateos-Mazón, Juan José Pérez, Sonia Andreu, Rafael Labrador, Jorge Ruiz, Mª Elena Velasquez, César Andrés Terol, Mª José Santiago, Raquel Vidal, Mª Jesús Campoy García, Fiz Villalón, Lucía Muiña, Begoña S. Soler, Joan Alfons Seri, Cristina Sánchez, Mª José Cuesta, Amalia Ramos, Rafael Sánchez-Montalvá, Adrián Ruiz-Camps, Isabel González, Marcos Abrisqueta, Pau Bosch, Francesc Exp Hematol Oncol Letter to the Editor BioMed Central 2020-12-18 /pmc/articles/PMC7746919/ /pubmed/33339537 http://dx.doi.org/10.1186/s40164-020-00195-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Muntañola, Ana
Villacampa, Guillermo
Hernández-Rivas, José Ángel
Alonso, Rosalía
Mirás, Fátima
Osorio, Santiago
Baile, Mónica
Baltasar, Patricia
López Jiménez, Javier
Hernandez-Rodriguez, Ines
Valenciano, Susana
Alfayate, Ana
Gimeno, Eva
Bárez, Abelardo
Oliveira, Ana C.
Riaza, Rosalía
Romero, Pilar
Delgado, Julio
Yáñez, Lucrecia
Zabalza, Amaya
Torres, Ana
Gómez-Roncero, Mª Isabel
Crespo, Marta
Córdoba, Raúl
Mateos-Mazón, Juan José
Pérez, Sonia
Andreu, Rafael
Labrador, Jorge
Ruiz, Mª Elena
Velasquez, César Andrés
Terol, Mª José
Santiago, Raquel
Vidal, Mª Jesús
Campoy García, Fiz
Villalón, Lucía
Muiña, Begoña S.
Soler, Joan Alfons
Seri, Cristina
Sánchez, Mª José
Cuesta, Amalia
Ramos, Rafael
Sánchez-Montalvá, Adrián
Ruiz-Camps, Isabel
González, Marcos
Abrisqueta, Pau
Bosch, Francesc
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
title Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
title_full Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
title_fullStr Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
title_full_unstemmed Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
title_short Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
title_sort clinical characteristics and outcome of sars-cov-2 infection in admitted patients with chronic lymphocytic leukemia from a single european country
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746919/
https://www.ncbi.nlm.nih.gov/pubmed/33339537
http://dx.doi.org/10.1186/s40164-020-00195-x
work_keys_str_mv AT muntanolaana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT villacampaguillermo clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT hernandezrivasjoseangel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT alonsorosalia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT mirasfatima clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT osoriosantiago clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT bailemonica clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT baltasarpatricia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT lopezjimenezjavier clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT hernandezrodriguezines clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT valencianosusana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT alfayateana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT gimenoeva clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT barezabelardo clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT oliveiraanac clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT riazarosalia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT romeropilar clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT delgadojulio clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT yanezlucrecia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT zabalzaamaya clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT torresana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT gomezronceromaisabel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT crespomarta clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT cordobaraul clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT mateosmazonjuanjose clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT perezsonia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT andreurafael clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT labradorjorge clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT ruizmaelena clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT velasquezcesarandres clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT terolmajose clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT santiagoraquel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT vidalmajesus clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT campoygarciafiz clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT villalonlucia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT muinabegonas clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT solerjoanalfons clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT sericristina clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT sanchezmajose clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT cuestaamalia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT ramosrafael clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT sanchezmontalvaadrian clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT ruizcampsisabel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT gonzalezmarcos clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT abrisquetapau clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT boschfrancesc clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry
AT clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry